Preferences for surrogate designation and decision-making process in older versus younger adults with cancer: A comparative cross-sectional study.


Journal

Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280

Informations de publication

Date de publication:
03 2019
Historique:
received: 09 05 2018
revised: 27 09 2018
accepted: 28 09 2018
pubmed: 9 10 2018
medline: 7 9 2019
entrez: 9 10 2018
Statut: ppublish

Résumé

To compare the preferences of older (≥70 years old) versus younger (<70 years old) cancer patients regarding surrogate designation and decision making. A cross-sectional survey. Patient characteristics and information about surrogacy and involvement in decision making were collected. Associations between patient characteristics and preferences were examined. The study included 130 patients aged ≥70 years (mean age 80 years) and 102 patients aged <70 years (mean age 55) and. Factors independently associated with surrogate knowledge (66%): younger age, more children living nearby, high income; factors associated with having already designated a surrogate (62%): younger age, decreased number of daily medications; factors associated with designating a surrogate after questionnaire administration (40%): low education, metastasis. Patients requiring an informed consent for any intervention was associated with older age (adjusted OR [aOR] All cancer patients, wanted to be fully informed and 72% wanted to be involved in medical decisions. Preferences for decision control vary between age groups, depending on family members' presence and living alone. Sharing complete and clear information should be an important key in the process of cancer patients' care, regardless of patient age.

Identifiants

pubmed: 30293935
pii: S0738-3991(18)30814-0
doi: 10.1016/j.pec.2018.09.024
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

429-435

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Claudia Martinez-Tapia (C)

Paris-Est University, UPEC, DHU A-TVB, IMRB- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France. Electronic address: claudia.tapia@aphp.fr.

Florence Canoui-Poitrine (F)

Paris-Est University, UPEC, DHU A-TVB, IMRB- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France; Assistance Publique Hôpitaux de Paris (AP-HP), Henri-Mondor Hospital, Public Health Department, Créteil, France.

Philippe Caillet (P)

Paris-Est University, UPEC, DHU A-TVB, IMRB- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Henri-Mondor Hospital, Internal Medicine and Geriatric Department, Paris- Sud-Val-de-Marne Geriatric Oncology Clinic, Créteil, France; AP-HP, Georges-Pompidou European Hospital (HEGP), Geriatric Department, Paris, France.

Sylvie Bastuji-Garin (S)

Paris-Est University, UPEC, DHU A-TVB, IMRB- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France; Assistance Publique Hôpitaux de Paris (AP-HP), Henri-Mondor Hospital, Public Health Department, Créteil, France; AP-HP, Henri-Mondor Hospital, Clinical Research Unit (URC Mondor), Créteil, France.

Christophe Tournigand (C)

AP-HP, Henri-Mondor Hospital, Department of Medical Oncology, Créteil, France; Paris-Est University, UPEC, EC2M3 Unit, VIC DHU, Créteil, France.

Elias Assaf (E)

AP-HP, Henri-Mondor Hospital, Department of Medical Oncology, Créteil, France.

Gwénaëlle Varnier (G)

AP-HP, Henri-Mondor Hospital, Internal Medicine and Geriatric Department, Paris- Sud-Val-de-Marne Geriatric Oncology Clinic, Créteil, France.

Frederic Pamoukdjian (F)

APHP, Avicenne Hospital, Geriatric department, Coordination Unit in Geriatric Oncology, Bobigny, France; Paris 13 University, Sorbonne Paris Cité, Health Education and Practices Laboratory, (LEPS EA3412), Bobigny, France.

Etienne Brain (E)

Institut Curie (Hôpital René Huguenin), Department of Medical Oncology, St Cloud, France.

Florence Rollot-Trad (F)

Institut Curie Hospital, Geriatric oncology and supportive care department, Paris, France.

Marie Laurent (M)

Paris-Est University, UPEC, DHU A-TVB, IMRB- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Henri-Mondor Hospital, Internal Medicine and Geriatric Department, Paris- Sud-Val-de-Marne Geriatric Oncology Clinic, Créteil, France.

Elena Paillaud (E)

Paris-Est University, UPEC, DHU A-TVB, IMRB- EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Créteil, France; AP-HP, Henri-Mondor Hospital, Internal Medicine and Geriatric Department, Paris- Sud-Val-de-Marne Geriatric Oncology Clinic, Créteil, France; AP-HP, Georges-Pompidou European Hospital (HEGP), Geriatric Department, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH